ID | 118051 |
Author |
Hashimoto, Noboru
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Liu, Yao
Tokushima University
Xia, Linze
Tokushima University
Nishihara, Takaaki
Tokushima University
Oki, Wakana
Tokushima University
Kawarabayashi, Keita
Tokushima University
Mizusawa, Noriko
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Aota, Keiko
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Sakai, Takayoshi
Osaka University
Azuma, Masayuki
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Hibi, Hideharu
Nagoya University
Iwasaki, Tomonori
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Horimai, Nobuyasu
Yushinkai Medical Cooperation
|
Content Type |
Journal Article
|
Description | Radiation therapy for head and neck cancers is frequently associated with adverse effects on the surrounding normal tissue. Irreversible damage to radiation-sensitive acinar cells in the salivary gland (SG) causes severe radiation-induced xerostomia (RIX). Currently, there are no effective drugs for treating RIX. We investigated the efficacy of treatment with conditioned medium derived from stem cells from human exfoliated deciduous teeth (SHED-CM) in a mouse RIX model. Intravenous administration of SHED-CM, but not fibroblast-CM (Fibro-CM), prevented radiation-induced cutaneous ulcer formation (p < 0.0001) and maintained SG function (p < 0.0001). SHED-CM treatment enhanced the expression of multiple antioxidant genes in mouse RIX and human acinar cells and strongly suppressed radiation-induced oxidative stress. The therapeutic effects of SHED-CM were abolished by the superoxide dismutase inhibitor diethyldithiocarbamate (p < 0.0001). Notably, quantitative liquid chromatography-tandem mass spectrometry shotgun proteomics of SHED-CM and Fibro-CM identified eight proteins activating the endogenous antioxidant system, which were more abundant in SHED-CM than in Fibro-CM (p < 0.0001). Neutralizing antibodies against those activators reduced antioxidant activity of SHED-CM (anti-PDGF-D; p = 0.0001, anti-HGF; p = 0.003). Our results suggest that SHED-CM may provide substantial therapeutic benefits for RIX primarily through the activation of multiple antioxidant enzyme genes in the target tissue.
|
Journal Title |
Scientific Reports
|
ISSN | 20452322
|
Publisher | Springer Nature
|
Volume | 13
|
Start Page | 2706
|
Published Date | 2023-02-15
|
Rights | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
|
EDB ID | |
DOI (Published Version) | |
URL ( Publisher's Version ) | |
FullText File | |
language |
eng
|
TextVersion |
Publisher
|
departments |
Oral Sciences
University Hospital
|